• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Fetoscopic endoluminal tracheal occlusion improves infant survival for congenital diaphragmatic hernia

byBoaz WongandHarsh Shah
June 24, 2021
in Obstetrics, Pediatrics, Pulmonology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Fetoscopic endoluminal tracheal occlusion (FETO) was shown to improve survival to discharge in infants with severe left congenital diaphragmatic hernia.

2. The FETO surgical procedure increased rates of preterm, prelabor membrane rupture preterm birth.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Severe congenital diaphragmatic hernia is a birth defect where abdominal contents herniate through the diaphragm and interfere with airway and pulmonary vascular development. Without medical intervention, these patients experience high rates of infant death due to respiratory failure and pulmonary hypertension. FETO, a surgical procedure inflating a balloon within the trachea of the fetus, decreases early neonatal respiratory complications. As such this study investigated the efficacy of FETO in infants with congenital diaphragmatic hernia. The study determined infants receiving FETO had a higher rate of survival to discharge compared to the control group. However, mothers in the FETO group notably experienced higher rates of preterm, prelabor rupture of membranes, and preterm birth. The major limitation of this study was the inability to assess the long-term outcomes of the procedure. Additionally, given that this procedure is highly specialized, and the trial was performed at an experienced fetoscopy center, data on rates of complications and its efficacy at less-experienced centers is warranted. Nonetheless, the study’s results are significant as the results provided evidence for the use of FETO in improving outcomes for infants with severe congenital diaphragmatic hernia.

Click to read the study in NEJM

Relevant Reading: Predictors of neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia undergoing fetoscopic tracheal occlusion

RELATED REPORTS

Prostacyclin therapy may decrease extracorporeal life support use in neonates with congenital diaphragmatic hernia

Prematurity plays significant role in mortality of premature neonates born with birth defects

Exposure to hydraulic fracturing sites is associated with some adverse birth outcomes

In-Depth [randomized controlled trial]: This study enrolled 80 pregnant mothers from 26 neonatal care centers in 12 countries. Patients with a maternal age of 18 years or older carrying a singleton pregnancy, confirmed fetal congenital diaphragmatic hernia, and severe pulmonary hypoplasia on the left side was included in the study. Patients with an elevated risk of preterm birth or maternal conditions increasing the risk of fetal surgery were excluded from the study. The patients were randomized in a 1:1 ratio to either receive FETO or expectant care, respectively. In the FETO group, balloon placement occurred between 27 to 29 weeks of gestation while removal of the balloon occurred around 34 weeks of gestation. The primary outcome was survival to discharge defined as the percentage of fetuses that were healthy to progress to discharge from the neonatal intensive care unit (NICU), post-delivery. Infants in the FETO group experienced significantly higher survival to discharge at 40% (16 of 40) compared to 15% (6 of 40) in the expectant care group (relative risk [RR], 2.67; 95% confidence interval [CI], 1.22-6.11, two-sided P=0.009). All surviving infants progressed to 6 months of age. The study was stopped early for superior efficacy in accordance with the O’Brien-Fleming stopping rules. Additionally, 47% of mothers in the FETO group experienced preterm, prelabor rupture of membranes compared to 11% in the expectant care group (RR, 4.51; 95% CI, 1.83-11.9), and 75% of mothers in the FETO group experienced preterm birth compared to 29% in the expectant care group (RR, 2.59; 95% CI, 1.59-4.52). Overall, FETO provided improved survival to discharge to 6 months of age in fetuses with severe, left congenital diaphragmatic hernia at the increased risk of preterm, prelabor membrane rupture, and delivery.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: birth defectscongenital diaphragmatic herniafetoscopic endoluminal tracheal occlusionpreterm premature rupture of membranes (PPROM)
Previous Post

A prospective evaluation of clinical HEART score agreement, accuracy, and adherence in emergency department chest pain patients

Next Post

Immediate kangaroo mother care decreased mortality in low-birth-weight infants

RelatedReports

Racial, ethnic differences in outcomes of extremely preterm infants decreasing but persistent
Cardiology

Prostacyclin therapy may decrease extracorporeal life support use in neonates with congenital diaphragmatic hernia

May 3, 2023
No decrease in infant mortality with maternal micronutrient supplementation in Bangladesh
Chronic Disease

Prematurity plays significant role in mortality of premature neonates born with birth defects

October 21, 2022
Risk of dementia with air pollution exposure amplified in patients with heart disease
Chronic Disease

Exposure to hydraulic fracturing sites is associated with some adverse birth outcomes

April 11, 2022
Evidence-based supportive therapy for bronchiolitis varies significantly between hospitals
Gastroenterology

Disproportionately higher mortality from gastrointestinal congenital anomalies among lower income countries

August 4, 2021
Next Post
Home visits in Ghana improve neonatal mortality

Immediate kangaroo mother care decreased mortality in low-birth-weight infants

Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors

Wellness Check: Exercise

Cancer to surpass heart disease as leading cause of death in the U.S. for higher-income persons

Proton therapy associated with reduced toxicity and equivalent survival outcomes vs radiation therapy amongst patients with nonmetastatic nasopharygneal carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Brain Activation Measured on Functional MRI Predicts Response to Certolizumab, a TNF Inhibitor, in Rheumatoid Arthritis
  • 2 Minute Medicine Rewind July 14, 2025
  • New obesity framework may reclassify over half of overweight individuals as people with obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.